These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38307349)

  • 1. Characterization of pathological stages in a mouse model of progressive multiple sclerosis.
    Hamano S; Yoshimizu T; Mori M; Iida A; Yamashita T
    Neurosci Res; 2024 Jul; 204():46-57. PubMed ID: 38307349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL; Wolak K; Fournier S; David S
    Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cuprizone-Dependent De/Remyelination Responses and Functional Correlates in Mouse Strains Adopted to Model Relapsing, Chronic and Progressive Experimental Autoimmune Encephalomyelitis.
    Buonvicino D; Ranieri G; Chiarugi A
    Neurotox Res; 2021 Jun; 39(3):658-666. PubMed ID: 33475965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia suppress the secondary progression of autoimmune encephalomyelitis.
    Tanabe S; Saitoh S; Miyajima H; Itokazu T; Yamashita T
    Glia; 2019 Sep; 67(9):1694-1704. PubMed ID: 31106910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8.
    Sánchez-Fernández A; Zandee S; Amo-Aparicio J; Charabati M; Prat A; Garlanda C; Eisenmesser EZ; Dinarello CA; López-Vales R
    Theranostics; 2021; 11(1):1-13. PubMed ID: 33391457
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroimmunological characterization of a mouse model of primary progressive experimental autoimmune encephalomyelitis and effects of immunosuppressive or neuroprotective strategies on disease evolution.
    Buonvicino D; Ranieri G; Pratesi S; Guasti D; Chiarugi A
    Exp Neurol; 2019 Dec; 322():113065. PubMed ID: 31536728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling compartmentalized chronic immune-mediated demyelinating CNS disease in the Biozzi ABH mouse.
    Nishri Y; Fainstein N; Goldfarb S; Hampton D; Macrini C; Meinl E; Chandran S; Ben-Hur T
    J Neuroimmunol; 2021 Jul; 356():577582. PubMed ID: 33910137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune encephalomyelitis in NOD mice is not initially a progressive multiple sclerosis model.
    Baker D; Nutma E; O'Shea H; Cooke A; Orian JM; Amor S
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1362-1372. PubMed ID: 31402611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis.
    Colpitts SL; Kasper EJ; Keever A; Liljenberg C; Kirby T; Magori K; Kasper LH; Ochoa-Repáraz J
    Gut Microbes; 2017 Nov; 8(6):561-573. PubMed ID: 28708466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair.
    Hasselmann JPC; Karim H; Khalaj AJ; Ghosh S; Tiwari-Woodruff SK
    J Neurosci Methods; 2017 Jun; 284():71-84. PubMed ID: 28396177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of B cell subsets in central pathological process of autoimmune encephalomyelitis in mice.
    Xiong Y; Cheng S; Wu X; Ren Y; Xie X
    BMC Immunol; 2019 Jul; 20(1):24. PubMed ID: 31286875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects.
    de Lago E; Moreno-Martet M; Cabranes A; Ramos JA; Fernández-Ruiz J
    Neuropharmacology; 2012 Jun; 62(7):2299-308. PubMed ID: 22342378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
    Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
    Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early derangement of axonal mitochondria occurs in a mouse model of progressive but not relapsing-remitting multiple sclerosis.
    Buonvicino D; Ranieri G; Guasti D; Pistolesi A; La Rocca AI; Rapizzi E; Chiarugi A
    Neurobiol Dis; 2023 Mar; 178():106015. PubMed ID: 36702320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling MS: Chronic-Relapsing EAE in the NOD/Lt Mouse Strain.
    Dang PT; Bui Q; D'Souza CS; Orian JM
    Curr Top Behav Neurosci; 2015; 26():143-77. PubMed ID: 26126592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental autoimmune encephalomyelitis (EAE) IN C57Bl/6 mice is not associated with astrogliosis.
    Pham H; Doerrbecker J; Ramp AA; D'Souza CS; Gorasia DG; Purcell AW; Ayers MM; Orian JM
    J Neuroimmunol; 2011 Mar; 232(1-2):51-62. PubMed ID: 21056916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in spinal cord stiffness in the course of experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
    Pyka-Fościak G; Zemła J; Lis GJ; Litwin JA; Lekka M
    Arch Biochem Biophys; 2020 Feb; 680():108221. PubMed ID: 31816310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
    Breakell T; Tacke S; Schropp V; Zetterberg H; Blennow K; Urich E; Kuerten S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.